J&J | صافي الدخل



Net Income تغيير تاريخ
AbbVie USD 938M 348M 2025-06
Abbott USD 1.78B 454M 2025-06
Amgen USD 1.43B 298M 2025-06
AstraZeneca USD 2.45B 466M 2025-06
Baxter International USD 91M 35M 2025-06
Bayer EUR -199000000 1.5B 2025-06
Becton, Dickinson and Co. USD 574M 266M 2025-06
Biogen USD 634.8M 394.3M 2025-06
Boston Scientific USD 797M 123M 2025-06
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
CONMED USD 21.42M 15.38M 2025-06
Cooper Companies USD 98.3M 10.6M 2025-07
Dexcom USD 179.8M 74.4M 2025-06
Edwards Lifesciences USD 333.2M 24.8M 2025-06
Eli Lilly USD 5.66B 2.9B 2025-06
Gilead Sciences USD 1.96B 645M 2025-06
GlaxoSmithKline GBP 1.44B 181M 2025-06
Globus Medical USD 202.85M 127.38M 2025-06
Hologic USD 194.9M 212.3M 2025-06
Insulet USD 22.5M 12.9M 2025-06
Integra LifeSciences USD -484073000 458.78M 2025-06
Intuitive Surgical USD 658.4M 40M 2025-06
J&J USD 5.54B 5.46B 2025-06
Medtronic USD 1.04B 17M 2025-07
Merck USD 4.43B 652M 2025-06
Merit Medical Systems USD 32.58M 2.43M 2025-06
Novartis USD 4.02B 418M 2025-06
Pfizer USD 2.91B 58M 2025-06
Regeneron Pharmaceuticals USD 1.39B 582.9M 2025-06
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 3.94B 2.07B 2025-06
Stryker USD 884M 230M 2025-06
Tandem Diabetes Care USD -52400000 78.16M 2025-06
Teva Pharmaceutical Industries USD 282M 68M 2025-06
Vertex Pharmaceuticals USD 1.03B 386.6M 2025-06
Zimmer Biomet Holdings USD 152.8M 29.2M 2025-06
Zoetis USD 718M 87M 2025-06


J&J صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Sep 2025.